Zepbound (tirzepatide) is a prescription medication approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Medical Disclaimer Prescription & FDA Status: All treatments, including BPC-157, TB-500, Semaglutide, and Tirzepatide, require a medical consultation and are issued at the providers discretion
Bitter Herbs and Foods with GLP-1 Agonist Activity Bitter foods and herbs, like arugula, dandelion leaf and root, gentian root, burdock root and many others, have a long history of use for supporting digestive processes
Through multi-target activation, innovative delivery methods, and expanded indications, GLP-1-based agents are poised to drive transformative advances in metabolic disease management and chronic care models, demonstrating significant future potential (32)